Polymyxin B-12

General Information


DRACP ID  DRACP04262

Peptide Name   Polymyxin B-12

Sequence  TXXXfLXXT

Sequence Length  9

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C8

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C14H15N3

Absent amino acids  ACDEFGHIKMNPQRSVWY

Common amino acids  X

Mass  91816

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  -22

Hydrophobicity  26.67

Aliphatic Index  43.33

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 36708325

Title  Discovery of Biologically Optimized Polymyxin Derivatives Facilitated by Peptide Scanning and In Situ Screening Chemistry

Doi Not available

Year  2023

Literature 2

Pubmed ID 26734854

Title  Activity and Predicted Nephrotoxicity of Synthetic peptide Antibiotics Based on Polymyxin B

Doi Not available

Year  2016

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18759

DRACP is developed by Dr.Zheng's team.